|
|
Line 216: |
Line 216: |
| | | |
| This experiment showed that not any native <i>E. coli</i> BL21(DE3) cell without a chloramphenicol resistance gene is able to grow above c(Cm)= 1 μg μL<sup>-1</sup>. Based on this experiment we chose c(Cm)= 3 μg μL<sup>-1</sup> to exclude any growth from <i>E. coli</i> BL21(DE3) during our cultivation for the UBP retention. | | This experiment showed that not any native <i>E. coli</i> BL21(DE3) cell without a chloramphenicol resistance gene is able to grow above c(Cm)= 1 μg μL<sup>-1</sup>. Based on this experiment we chose c(Cm)= 3 μg μL<sup>-1</sup> to exclude any growth from <i>E. coli</i> BL21(DE3) during our cultivation for the UBP retention. |
− | <br><br>Another pretest should investigate the influence of the unnatural nucleotidetriphosphates isoGTP and isoC<sup>m</sup>TP on the growth the chemically competent cells <i>E. coli</i> BL21(DE3) containing the pSB1K3 high-copy plasmid <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a>. Therefore we inoculated these cells in 2xYT supplemented with 50 μg μL<sup>-1</sup> kanamycin and different concentrations c= 5, 10, 50, 100 μM of each unnatural nucleotidetriphosphate. The different concentrations of unnatural nucleotidetriphosphates did not show any influence on the growth of the cells. | + | <br><br>Another pretest should investigate the influence of the unnatural nucleotidetriphosphates isoGTP and isoC<sup>m</sup>TP on the growth the chemically competent cells <i>E. coli</i> BL21(DE3) containing the pSB1K3 high-copy plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a>. Therefore we inoculated these cells in 2xYT supplemented with 50 μg μL<sup>-1</sup> kanamycin and different concentrations c= 5, 10, 50, 100 μM of each unnatural nucleotidetriphosphate. The different concentrations of unnatural nucleotidetriphosphates did not show any influence on the growth of the cells. |
| | | |
| <div class="figure seventy"> | | <div class="figure seventy"> |
| <img class="figure image" src="https://static.igem.org/mediawiki/2017/9/91/Ubp_conc_test_growth.png"> | | <img class="figure image" src="https://static.igem.org/mediawiki/2017/9/91/Ubp_conc_test_growth.png"> |
− | <p class="figure subtitle"><b>Figure (9): Growth test of chemically competent cells <i>E. coli</i> BL21(DE3) containing <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a> with different concentrations of isoGTP and isoC<sup>m</sup>.</b> | + | <p class="figure subtitle"><b>Figure (9): Growth test of chemically competent cells <i>E. coli</i> BL21(DE3) containing <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> with different concentrations of isoGTP and isoC<sup>m</sup>.</b> |
− | <br> The plasmid <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a> is coding for the nucleotide transporter <a href=” https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/uptake_and_biosynthesis”>PtNTT2</a> which ensures the uptake of isoGTP and isoC<sup>m</sup> from the surrounding media into the cell. The cells were incubated in 500 μL 2xYT media at 37 °C for 1 h. For incubation at 37 °C and 600 rpm in 12-well plates in the VWR – Incubation Microplate Shaker 2xYT media was added to 1 mL with 50 μg μL<sup>-1</sup> kanamycin and c= 5, 10, 50, 100 μM of each isoGTP and isoC<sup>m</sup>TP final concentration. Three technical replicates of the OD<sub>600</sub> were measured every hour via the NanoDrop ND-1000 Spectrophotometer.</p> | + | <br> The plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> is coding for the nucleotide transporter <a href=" https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/uptake_and_biosynthesis">PtNTT2</a> which ensures the uptake of isoGTP and isoC<sup>m</sup> from the surrounding media into the cell. The cells were incubated in 500 μL 2xYT media at 37 °C for 1 h. For incubation at 37 °C and 600 rpm in 12-well plates in the VWR – Incubation Microplate Shaker 2xYT media was added to 1 mL with 50 μg μL<sup>-1</sup> kanamycin and c= 5, 10, 50, 100 μM of each isoGTP and isoC<sup>m</sup>TP final concentration. Three technical replicates of the OD<sub>600</sub> were measured every hour via the NanoDrop ND-1000 Spectrophotometer.</p> |
| </div> | | </div> |
| | | |
Line 238: |
Line 238: |
| | | |
| <article> | | <article> |
− | The retention system was engineered to preserve the unnatural base pair (UBP) isoG-isoC<sup>m</sup> <i>in vivo</i>. This intention requires the uptake of unnatural nucleotides from the media and a selection pressure on the plasmids carrying the UBP. We developed a two-plasmid system for the retention. As described above, the first high-copy plasmid (pSB1K3) <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a> contains the truncated version of <i>PtNTT2</i> for the uptake of isoGTP and isoC<sup>m</sup>TP and <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/preservation_system"><i>cas9</i> for the digestion of all plasmids that have lost the UBP <i>in vivo</i></a>. The Cas9 is guided by five sgRNAs (<a href=” http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201077”>BBa_K2201077</a>) that bind every possible point mutation that leads to the loss of the UBP. Those sgRNAs are part of the second plasmid. This plasmid <a href=” http://parts.igem.org/Part:BBa_K2201032”>BBa_K2201032</a> is a composite part of <a href=” http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201077”>BBa_K2201077</a> and <a href=” http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201017”>BBa_K2201017</a>. We decided this plasmid to be a low-copy plasmid (pSB3C5), because a high-copy version could possibly cause a greater mutation frequency. The second plasmid also contains a different antibiotic resistance than the first plasmid for a selection of bacteria carrying both plasmids. The UBP was part of the oligo <a href=””>UBP_target</a> and was assembled with the linearized backbone of <a href=” http://parts.igem.org/Part:BBa_K2201032”>BBa_K2201032</a>. Primers (<a href=”https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides”>17tx and 17we</a>) for the linearization via PCR were used so that the Gibson Assembly with the oligo <a href=””>UBP_target</a> leads to a frameshift within the <i>sacB</i> coding sequence of the mRFP-sacB fusionprotein. Hence, a successful Gibson Assembly enables the transformed organism to grow in the presence of sucrose later on. | + | The retention system was engineered to preserve the unnatural base pair (UBP) isoG-isoC<sup>m</sup> <i>in vivo</i>. This intention requires the uptake of unnatural nucleotides from the media and a selection pressure on the plasmids carrying the UBP. We developed a two-plasmid system for the retention. As described above, the first high-copy plasmid (pSB1K3) <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> contains the truncated version of <i>PtNTT2</i> for the uptake of isoGTP and isoC<sup>m</sup>TP and <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/preservation_system"><i>cas9</i> for the digestion of all plasmids that have lost the UBP <i>in vivo</i></a>. The Cas9 is guided by five sgRNAs (<a href=" http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201077">BBa_K2201077</a>) that bind every possible point mutation that leads to the loss of the UBP. Those sgRNAs are part of the second plasmid. This plasmid <a href=" http://parts.igem.org/Part:BBa_K2201032">BBa_K2201032</a> is a composite part of <a href=" http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201077">BBa_K2201077</a> and <a href=" http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201017">BBa_K2201017</a>. We decided this plasmid to be a low-copy plasmid (pSB3C5), because a high-copy version could possibly cause a greater mutation frequency. The second plasmid also contains a different antibiotic resistance than the first plasmid for a selection of bacteria carrying both plasmids. The UBP was part of the oligo <a href="">UBP_target</a> and was assembled with the linearized backbone of <a href=" http://parts.igem.org/Part:BBa_K2201032">BBa_K2201032</a>. Primers (<a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides">17tx and 17we</a>) for the linearization via PCR were used so that the Gibson Assembly with the oligo <a href="">UBP_target</a> leads to a frameshift within the <i>sacB</i> coding sequence of the mRFP-sacB fusionprotein. Hence, a successful Gibson Assembly enables the transformed organism to grow in the presence of sucrose later on. |
| | | |
| </article> | | </article> |
Line 254: |
Line 254: |
| | | |
| <article> | | <article> |
− | The Romesberg lab (Zhang <i>et al.</i>, 2017) was able to proof retention of their hydrophobic UBP in <i>E. coli</i> BL21(DE3) using the nucleotide transporter PtNTT2 and Cas9. Therefore we transformed <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a> into <i>E. coli</i> BL21(DE3) via heat shock with the goal to produce chemically competent cells containing the retention plasmid afterwards. Those chemically competent cells were used for a second heat shock transformation of the second plasmid <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201032”>BBa_K2201032</a> containing our UBP isoG-isoC<sup>m</sup>. 10 μL of the above described Gibson Assembly was transformed into chemically competent cells. After the heat shock, the cells were recovered in liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C for 1 h. Growth was performed in liquid growth media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin) while shaking at 600 rpm and 37 °C for 24 h. The described experimental set-up is shown in Figure 10. | + | The Romesberg lab (Zhang <i>et al.</i>, 2017) was able to proof retention of their hydrophobic UBP in <i>E. coli</i> BL21(DE3) using the nucleotide transporter PtNTT2 and Cas9. Therefore we transformed <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> into <i>E. coli</i> BL21(DE3) via heat shock with the goal to produce chemically competent cells containing the retention plasmid afterwards. Those chemically competent cells were used for a second heat shock transformation of the second plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201032">BBa_K2201032</a> containing our UBP isoG-isoC<sup>m</sup>. 10 μL of the above described Gibson Assembly was transformed into chemically competent cells. After the heat shock, the cells were recovered in liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C for 1 h. Growth was performed in liquid growth media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin) while shaking at 600 rpm and 37 °C for 24 h. The described experimental set-up is shown in Figure 10. |
− | <br><br>K<sub>2</sub>HPO<sub>4</sub> is needed in the recovery and growth media as a competitive inhibitor for phosphatases. This prevents the dephosphorylation of unnatural nucleotide triphosphates. The IPTG in the media induces the expression of <i>cas9</i> that is negatively regulated by our designed <i>lac</i> operon (<a href=” http://parts.igem.org/Part:BBa_K2201020”>lacO_tight1</a>) optimized for tight repression. This needs to be added right from the beginning after the transformation to start the retention system during recovery. For the same reason the isoGTP and isoC<sup>m</sup>TP were added to the recovery and growth media. | + | <br><br>K<sub>2</sub>HPO<sub>4</sub> is needed in the recovery and growth media as a competitive inhibitor for phosphatases. This prevents the dephosphorylation of unnatural nucleotide triphosphates. The IPTG in the media induces the expression of <i>cas9</i> that is negatively regulated by our designed <i>lac</i> operon (<a href=" http://parts.igem.org/Part:BBa_K2201020">lacO_tight1</a>) optimized for tight repression. This needs to be added right from the beginning after the transformation to start the retention system during recovery. For the same reason the isoGTP and isoC<sup>m</sup>TP were added to the recovery and growth media. |
| | | |
− | <br><br>Before analyzing the efficiency of the UBP retention, the plasmids need to be isolated from the cultivation samples. But this leads to the isolation of both plasmids, the high-copy (pSB1K3) and low-copy (pSB3C5) plasmid. For the detection of the UBP, which lays on the pSB3C5 plasmid, the pSB1K3 plasmid needs to be digested by restriction enzymes. This can be achieved by the restriction enzymes <i>Pvu</i>I, <i>Nsi</i>I und <i>Bam</i>HI that are solely targeting the pSB1K3 plasmid <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a>. Afterwards, the remaining pSB3C5 plasmid can be prepared for the Oxford Nanopore Sequencing method in order to detect the UBP. | + | <br><br>Before analyzing the efficiency of the UBP retention, the plasmids need to be isolated from the cultivation samples. But this leads to the isolation of both plasmids, the high-copy (pSB1K3) and low-copy (pSB3C5) plasmid. For the detection of the UBP, which lays on the pSB3C5 plasmid, the pSB1K3 plasmid needs to be digested by restriction enzymes. This can be achieved by the restriction enzymes <i>Pvu</i>I, <i>Nsi</i>I und <i>Bam</i>HI that are solely targeting the pSB1K3 plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a>. Afterwards, the remaining pSB3C5 plasmid can be prepared for the Oxford Nanopore Sequencing method in order to detect the UBP. |
| | | |
| <div class="figure eighty"> | | <div class="figure eighty"> |
| <img class="figure image" src="https://static.igem.org/mediawiki/2017/6/60/In_vivo_UBP_experimente_%C3%BCbersicht.png"> | | <img class="figure image" src="https://static.igem.org/mediawiki/2017/6/60/In_vivo_UBP_experimente_%C3%BCbersicht.png"> |
| <p class="figure subtitle"><b>Figure (10): Experimental flowchart for UBP retention <i>in vivo</i>.</b> | | <p class="figure subtitle"><b>Figure (10): Experimental flowchart for UBP retention <i>in vivo</i>.</b> |
− | <br>The pSB3C5 plasmid <a href=” http://parts.igem.org/Part:BBa_K2201032”>BBa_K2201032</a> containing five sgRNAs and <i>mRFP-sacB</i> was linearized with the primers <a href=”https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides”>17tx and 17we</a> and assembled with <a href=””>UBP_target</a> via Gibson Assembly. 10 μL of the Gibson Assembly was transformed into chemically competent <i>E. coli</i> BL21(DE3) cells containing the pSB1K3-plasmid <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a>. After the heat shock, the cells were recovered in 850 μL liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 1 h. Then, the recovery media was filled up with liquid growth media (2xYT media added with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin for final concentrations) up to 1 mL and shaked at 600 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 24 h. Plasmid isolations were performed for single 1 mL cultures. The high-copy plasmid pSB1K3 <a href=”http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027”>BBa_K2201027</a> was digested by the restriction enzymes <i>Pvu</i>I, <i>Nsi</i>I und <i>Bam</i>HI. The remaining low-copy plasmid pSB3C5 containing the UBP was then prepared for the Oxford Nanopore Sequencing.</p> | + | <br>The pSB3C5 plasmid <a href=" http://parts.igem.org/Part:BBa_K2201032">BBa_K2201032</a> containing five sgRNAs and <i>mRFP-sacB</i> was linearized with the primers <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides">17tx and 17we</a> and assembled with <a href="">UBP_target</a> via Gibson Assembly. 10 μL of the Gibson Assembly was transformed into chemically competent <i>E. coli</i> BL21(DE3) cells containing the pSB1K3-plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a>. After the heat shock, the cells were recovered in 850 μL liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 1 h. Then, the recovery media was filled up with liquid growth media (2xYT media added with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin for final concentrations) up to 1 mL and shaked at 600 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 24 h. Plasmid isolations were performed for single 1 mL cultures. The high-copy plasmid pSB1K3 <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> was digested by the restriction enzymes <i>Pvu</i>I, <i>Nsi</i>I und <i>Bam</i>HI. The remaining low-copy plasmid pSB3C5 containing the UBP was then prepared for the Oxford Nanopore Sequencing.</p> |
| </div> | | </div> |
| | | |
Line 269: |
Line 269: |
| <div class="figure seventy"> | | <div class="figure seventy"> |
| <img class="figure image" src="https://static.igem.org/mediawiki/2017/a/ad/T--Bielefeld-CeBiTec--02112017--nanopore_sequencing_f%C3%BCr_results_ubp_retention2222.png"> | | <img class="figure image" src="https://static.igem.org/mediawiki/2017/a/ad/T--Bielefeld-CeBiTec--02112017--nanopore_sequencing_f%C3%BCr_results_ubp_retention2222.png"> |
− | <p class="figure subtitle"><b>Figure (11): Oxford Nanopore Sequencing of <a href=” http://parts.igem.org/Part:BBa_K2201032”>BBa_K2201032</a> containing the UBP after <i>in vivo</i> cultivation and retention.</b> | + | <p class="figure subtitle"><b>Figure (11): Oxford Nanopore Sequencing of <a href=" http://parts.igem.org/Part:BBa_K2201032">BBa_K2201032</a> containing the UBP after <i>in vivo</i> cultivation and retention.</b> |
| <br>The flow cell lays can be seen in the front. On the laptop screen: Green areas on the grid show the quantity of nanopores sequencing a DNA molecule at a moment. | | <br>The flow cell lays can be seen in the front. On the laptop screen: Green areas on the grid show the quantity of nanopores sequencing a DNA molecule at a moment. |
| </div> | | </div> |